Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel.

Flaherty MP, Johnston PV, Rade JJ.

J Invasive Cardiol. 2011 Jul;23(7):300-4.

2.

Comparison of the degree of platelet aggregation inhibition with prasugrel versus clopidogrel and clinical outcomes in patients with unprotected left main disease treated with everolimus-eluting stents.

Migliorini A, Valenti R, Parodi G, Marcucci R, Abbate R, Carrabba N, Gensini GF, Antoniucci D.

Am J Cardiol. 2013 Dec 15;112(12):1843-8. doi: 10.1016/j.amjcard.2013.08.009. Epub 2013 Sep 21.

PMID:
24063827
4.

Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.

Behr T, Kuch B, Behr W, von Scheidt W.

Clin Res Cardiol. 2011 Oct;100(10):907-14. doi: 10.1007/s00392-011-0321-4. Epub 2011 Apr 30.

PMID:
21533581
5.

Use of prasugrel in a patient with clopidogrel hypersensitivity.

Peppard SR, Held-Godgluck BM, Beddingfield R.

Ann Pharmacother. 2011 Oct;45(10):e54. doi: 10.1345/aph.1Q287. Epub 2011 Sep 6.

PMID:
21896923
6.

Failure of high-dose clopidogrel in recurrent stent thrombosis.

Li Y, Chan MY.

Singapore Med J. 2012 Aug;53(8):e166-8.

7.
8.

[Extent of platelet aggregation inhibition and clinical events: new evidence with prasugrel].

Abbate R, Crea F, De Servi S, Filippi E, Gensini GF, Golinos P, Savonitto S.

G Ital Cardiol (Rome). 2010 Feb;11(2):127-37. Review. Italian.

PMID:
20408476
10.

Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.

[No authors listed]

Prescrire Int. 2009 Oct;18(103):193-5.

PMID:
19877380
11.

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).

Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators.

Am Heart J. 2006 Oct;152(4):627-35.

PMID:
16996826
12.

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators.

N Engl J Med. 2007 Nov 15;357(20):2001-15. Epub 2007 Nov 4.

13.

Pharmacodynamic assessment of a novel P2Y12 receptor antagonist in Japanese patients with coronary artery disease undergoing elective percutaneous coronary intervention.

Yokoi H, Kimura T, Isshiki T, Ogawa H, Ikeda Y.

Thromb Res. 2012 May;129(5):623-8. doi: 10.1016/j.thromres.2011.11.023. Epub 2011 Dec 16.

PMID:
22178576
14.

Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition.

Barison A, de Carlo M, Bellini F, Capozza PF, Lunardini A, Petronio AS.

Acute Card Care. 2011 Mar;13(1):52-4. doi: 10.3109/17482941.2011.553288. Epub 2011 Feb 16.

PMID:
21323408
15.

Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.

Mousa SA, Jeske WP, Fareed J.

Clin Appl Thromb Hemost. 2010 Apr;16(2):170-6. doi: 10.1177/1076029609355589. Review.

PMID:
20299391
16.

Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity.

Niitsu Y, Jakubowski JA, Sugidachi A, Asai F.

Semin Thromb Hemost. 2005 Apr;31(2):184-94. Review.

PMID:
15852222
17.

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A, Kastrati A, von Beckerath N.

J Am Coll Cardiol. 2009 Mar 10;53(10):849-56. doi: 10.1016/j.jacc.2008.11.030.

18.

Intraoperative thrombosis of right coronary artery drug-eluting stent after 2 years of dual antiplatelet therapy.

Murray AT, Sederberg JH 2nd.

Semin Cardiothorac Vasc Anesth. 2011 Mar-Jun;15(1-2):40-3. doi: 10.1177/1089253211411105.

PMID:
21840879
19.

Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting.

Campo G, Valgimigli M, Carrescia C, Carletti R, Ferrari R.

Clin Appl Thromb Hemost. 2010 Oct;16(5):591-3. doi: 10.1177/1076029609337312. Epub 2009 Jun 10.

PMID:
19520678
20.

Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes.

Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M.

Basic Res Cardiol. 2010 May;105(3):379-87. doi: 10.1007/s00395-009-0073-8. Epub 2009 Nov 27.

PMID:
19943165

Supplemental Content

Support Center